HLN HLN
Company Profile ↓Company Overview
HLN (HLN) is a publicly traded company listed on with a market capitalization of $89.08B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 16.3% per year over the last five years.
Maintains a net profit margin of 15.1%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $11.03B (-1.8% YoY); net profit $1.67B.
- Trailing 12 Months Year-on-year growth — revenue -1.8%, earnings +15.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.5%, profit CAGR 16.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.53% |
| 1 Year: | -1.81% |
Compounded Profit Growth
| 5 Years: | 16.29% |
| 1 Year: | 15.60% |
Stock Price Performance
| 1 Year: | +6.66% |
| 6 Months: | -3.89% |
| 3 Months: | +8.51% |
| 1 Month: | +1.12% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)54.93 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 16.3% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 |
|---|---|
| Revenue | 2.76B |
| Cost of Revenue | 1.23B |
| Gross Profit | 1.53B |
| Operating Expenses | 1.18B |
| Operating Income | 350.00M |
| EBITDA | 399.00M |
| Interest Expense | 111.00M |
| Pretax Income | 288.00M |
| Tax Provision | 66.00M |
| Net Income | 231.00M |
| Diluted EPS | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 10.86B | 11.30B | 11.23B | 11.03B |
| Cost of Revenue | 4.28B | 4.55B | 4.41B | 3.95B |
| Gross Profit | 6.58B | 6.75B | 6.82B | 7.08B |
| Operating Expenses | 4.75B | 4.75B | 4.62B | 4.67B |
| Operating Income | 1.82B | 2.00B | 2.21B | 2.41B |
| EBITDA | 2.18B | 2.35B | 2.63B | 2.86B |
| Interest Expense | 278.00M | 414.00M | 394.00M | 347.00M |
| Pretax Income | 1.62B | 1.63B | 1.91B | 2.15B |
| Tax Provision | 499.00M | 517.00M | 435.00M | 472.00M |
| Net Income | 1.06B | 1.05B | 1.44B | 1.67B |
| Diluted EPS | 0.23 | 0.23 | 0.31 | 0.37 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 34.81B | 34.05B | 34.31B | 32.63B |
| Current Assets | - | 4.06B | 4.82B | 5.72B | 4.55B |
| Cash & Equivalents | - | 606.00M | 994.00M | 2.19B | 1.26B |
| Inventory | - | 1.35B | 1.41B | 1.19B | 1.02B |
| Receivables | - | 1.49B | 1.35B | 1.59B | 1.64B |
| Total Liabilities | - | 18.36B | 17.33B | 18.09B | 16.15B |
| Current Liabilities | - | 4.37B | 4.64B | 5.81B | 4.93B |
| Long Term Debt | - | 9.89B | 8.69B | 8.54B | 7.66B |
| Total Debt | - | 10.44B | 9.43B | 10.10B | 8.58B |
| Total Equity | - | 16.33B | 16.61B | 16.17B | 16.43B |
| Shares Outstanding | - | 9.23B | 9.23B | 9.12B | 8.95B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.06B | 2.10B | 2.30B | 2.63B |
| Investing Cash Flow | - | -8.78B | -134.00M | 528.00M | -346.00M |
| Financing Cash Flow | - | 6.91B | -1.57B | -1.54B | -3.14B |
| Capital Expenditure | - | -328.00M | -336.00M | -318.00M | -413.00M |
| Free Cash Flow | - | 1.74B | 1.76B | 1.98B | 2.22B |
| Net Change in Cash | - | 190.00M | 398.00M | 1.29B | -855.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 60.6% | 59.7% | 60.7% | 64.2% |
| Operating Margin % | 16.8% | 17.7% | 19.6% | 21.9% |
| Net Margin % | 9.8% | 9.3% | 12.8% | 15.1% |
| ROE % | 6.5% | 6.3% | 8.9% | 10.1% |
| ROCE % | 6.0% | 6.8% | 7.7% | 8.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HLN
ACCO vs. HLN: Which Stock Is the Better Value Option? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOTXI2UENLMkJNaDZDWVM2bHZhRUdxWHByRy1qNzFOMHZNNTdXQmRqdWJXRi1Zand6bDFDMzNaTG1IQUxUQnhyZTJobVRTeGpRR0FDYUUtRWNLSkQyQnVvaWkwTjVfUTdjVFVwVFJFM0JXRWVKMk5jUVY3cmdQa3hBa0NKa3duRjZYNG90Un…
55% Avoid Ice Cream Because of Sensitive Teeth; Sensodyne Plans Test - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOdlhQWEpmajIzMXZmWWx6ZjR2ekdVbllQMGtjeHNOTXFad29XcEg2TjB6VHZpLWZmdDg2b1ZGVkxrSE1JZUFyZ1lMakZlVzhHbmhyMFk2b2cySkJQUlI2WUd4Nl8zcHZoeS1wY21YYy1XUjAwYlhjRUJQZTY0Yzg2X1dsRGh0VnVsd2tBZn…
Haleon plc (HLN) Stock Analysis: With a 19% Potential Upside, Is This Healthcare Giant a Buy? - DirectorsTalk Interviews
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNSmVpVkNEZlNmYVEtbkR2VGJEdzlCcU9QWDhqQXVGZmFaRDZmQmxBSXhvdHplU1F3aXR2bVhBZlFCUTU3OUd3TDZObkdwU21TOERSUlhQQUZlcnJCOHNBbU5sLTJXR1NfeDNDUUsyZGM3THhrSTM3X2duRW9Lbm1RR0RDR0hGOTV0Q2k3UF…
Deutsche Bank Sticks to Its Sell Rating for Haleon PLC (HLN) - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNOGM0M2VudU5uS3plNExCVkFJbVVEVzluUXpibDdDbXJZcmhHVHM5YmhiaFpxaWtWVzlONHNQbFhGYmxtT3hGNm4xenBKMkVXTGh1bDk0WFEyNnE4Z3hZOEhtMDJGVUVwZVpVRlRLd3k0RW1IQk03SF8zejRqRHViQmdudzNyelpRZ09TVV…
HLN Stock Price and Chart — LSE:HLN - TradingView
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE92MWU0bUhGdlZWak5NS0tjVG16SEVvMEZBdTNlSGFQS3FCemEtOGNNT3pQdWxUemdoUk4yWlZBc0N4bGhrNVVDVVVrbno1RkZUZWFGSmVuSQ?oc=5" target="_blank">HLN Stock Price and Chart — LSE:HLN</a> &nbs…
(HLN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWnVoWVNnV1ZhR2dxS1RuaUJod3hEOWU5bFdaQ1pPNWlnWllpNWNzNG5zUXctZzhZSFpXem5rYXU2UEhheVQ0Y3ctZUEyOWIzZDE4QThEUXgwOF9BQWVoeGRNWDhuRVJUZVY5SENENDN0RlRZV0FKa1NVT3NVLUw1VVZWY1lNMlZfRGlrc3…
HLN — Frequently Asked Questions
What is the current share price of HLN?
As of 2026-08-05 17:25 PDT, HLN trades at $9.95 on NASDAQ/NYSE. Its 52-week range is $8.61 to $11.12.
What is the market capitalisation of HLN?
HLN has a market capitalisation of $89.08B on NASDAQ/NYSE.
What is the P/E ratio of HLN?
HLN trades at a trailing price-to-earnings (P/E) ratio of 26.89. Its price-to-book (P/B) ratio is 5.42.
What is the return on equity (ROE) of HLN?
HLN has a return on equity (ROE) of 10.15%. Its return on capital employed (ROCE) is 8.71%.
Is HLN a good stock to buy?
This page provides a data-driven analysis of HLN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.